3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
NETWORK
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
51
Urinary Bladder Neoplasms
15
Breast Neoplasms
10
Carcinoma, Renal Cell
8
Colorectal Neoplasms
7
Neoplasms
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Carcinoma, Transitional Cell
5
Carcinoma, Non-Small-Cell Lung
4
Motor Activity
3
Colonic Neoplasms
3
Urologic Neoplasms
2
Urologic Diseases
2
Ureteral Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Recurrence
2
Rectal Neoplasms
2
Prostate Cancer Metastatic
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Melanoma
2
Kidney Neoplasms
2
Kidney Failure, Chronic
2
Esophageal Neoplasms
2
COVID-19
2
Breast Neoplasms, Male
2
Interventions
enzalutamide
7
Prednisone
7
cabazitaxel
6
Radiosurgery
6
Docetaxel
5
Androgen Antagonists
4
Abiraterone Acetate
4
XRP6258
2
Standard of Care
2
talazoparib
1
sipuleucel-T
1
rucaparib
1
pembrolizumab
1
olaparib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
darolutamide
1
apalutamide
1
Zuclomiphene
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Prednisolone
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Midazolam
1
Lutetium-177
1
Lutetium
1
Lenograstim
1
LY3023414
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Prostate Cancer Metastatic
×
Standard of Care
×
Genitourinary
×
Clear all
NCT03784755
2026-03-27
PLATON
Canadian Cancer Trials Group
Phase NA
Active not recruiting
409 enrolled
NCT01360840
2015-12-14
PERSEUS
EMD Serono
Phase 2
Completed
180 enrolled
23 charts